Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 1498 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

ORIGINAL ARTICLE

Relationship of associated secondary hyperparathyroidism to serum fibroblast growth factor-23 in end stage renal disease: A case-control study

Sliem Hamdy, Tawfik Gamal, Moustafa Fadia, Zaki Heba

Year : 2011| Volume: 15| Issue : 2 | Page no: 105-109

   This article has been cited by
 
1 Myelofibrosis-Induced Erythropoietin-Resistant Anemia Due to Severe Refractory Hyperparathyroidism
Sidharth Kumar Sethi,Shyam Bansal,Nikita Wadhwani,Mayur Makasana,Ashish Nandwani,Vijay Kher,Rupesh Raina
Kidney International Reports. 2018;
[Pubmed]  [Google Scholar] [DOI]
2 Relationship of circulating levels of 25(OH)D with parathyroid hormone in various stages of chronic kidney disease
Mojgan Jalalzadeh,Seyed Nouraddin Mousavinasab,Ali Rostami
Journal of Renal Injury Prevention. 2017; 6(4): 264
[Pubmed]  [Google Scholar] [DOI]
3 The effect of renin-angiotensin system inhibitors on intact parathyroid hormone levels in peritoneal dialysis patients
Luyan Gao,Zhi Wang,Sheng Feng,Shan Jiang,Han Ouyang,Yongbing Shi,Huaying Shen
Journal of the Renin-Angiotensin-Aldosterone System. 2015; 16(4): 1260
[Pubmed]  [Google Scholar] [DOI]
4 High Dose ESAs Are Associated with High iPTH Levels in Hemodialysis Patients with End-Stage Kidney Disease: A Retrospective Analysis
Lan Chen,Yi-Sheng Ling,Chun-Hua Lin,Jin-Xuan He,Tian-Jun Guan
Frontiers in Public Health. 2015; 3
[Pubmed]  [Google Scholar] [DOI]
5 Prognostic Importance of Fibroblast Growth Factor-23 in Dialysis Patients
Nilgül Akalin,Yildiz Okuturlar,Özlem Harmankaya,Asuman Gedikbasi,Selçuk Sezikli,Sibel Koçak Yücel
International Journal of Nephrology. 2014; 2014: 1
[Pubmed]  [Google Scholar] [DOI]
6 Optimal use of phosphate binders in chronic kidney disease
Makrouhi Sonikian,Evangelos Papachristou,Dimitrios S Goumenos
Expert Opinion on Pharmacotherapy. 2013; 14(18): 2521
[Pubmed]  [Google Scholar] [DOI]

 

Read this article